Jay Kalin
PhD
The Janssen Pharmaceutical Companies of Johnson and Johnson

About
Scientist, Lead Discovery & Profiling
The Janssen Pharmaceutical Companies of Johnson and Johnson
The Janssen Pharmaceutical Companies of Johnson and Johnson
1125 Trenton Harbourton Rd, Titusville, NJ 08560
research
Interests

High-Grade Glioma
High-grade Gliomas (HGG) or astrocytomas in children nearly always result in a dismal prognosis. Although novel therapeutic approaches are currently in development, preclinical testing has been limited, due to a lack of pediatric-specific HGG preclinical models. These models are needed to help test
348
63

Diffuse Intrinsic Pontine Glioma
A presumptive diagnosis of DIPG based on classic imaging features, in the absence of a histologic diagnosis, has been routinely employed. Increasingly however, histologic confirmation is obtained for both entry into research studies and molecular characterization of the tumor.[5] New approaches with
136
31